Replies to post #33 on TBG Diagnostics Ltd fka TDLAF

[busker]

My thoughts?

Word has it that institutions are now active buyers of Progen stock on ASX.

Once Progen agree with FDA on the phase3 design and the SPA is approved phase3 will commence and a lot of uncertainty will be removed and the price should act accordingly.

Currently way below the consensus of the main brokers who are following the company closely. Their valuations are between A$14-A$16 (~US$13)

With PGLA trading ~US$3 it is a gift to me and I have been buying more recently.

Please do you own DD before buying.